title: Interferon-α for unresectable progressive and symptomatic plexiform neurofibromas.
abstract: Neurofibromas are the most common manifestations of neurofibromatosis type-1. They occasionally cause pain or progressive loss of function due to nerve compression. Optimal treatment approach is still challenging and the current treatment results are not satisfactory. Four cases of plexiform neurofibromas with various clinical presentations and an addendum to a previously published report on a patient who had relief from pain and/or regression of tumor volume after treatment with interferon-α 2a are presented.
authors.affiliation: Division of Pediatric Hematology-Oncology, Cerrahpaşa Medical Faculty, and Oncology Institute, Istanbul University, Istanbul, Turkey.
authors.forename: Rejin
authors.initials: R
authors.lastname: Kebudi
authors.forename: Fatma B
authors.initials: FB
authors.lastname: Cakir
authors.forename: Omer
authors.initials: O
authors.lastname: Gorgun
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D018318:Neurofibroma, Plexiform / Q000188:drug therapy* / Q000473:pathology; D009456:Neurofibromatosis 1 / Q000188:drug therapy* / Q000473:pathology; D011379:Prognosis; D012189:Retrospective Studies
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha